New drug aims to halt lung decline in scarred lungs
NCT ID NCT06736990
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This phase 2 trial tests whether the investigational drug CAL101 can slow the loss of lung function in adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs. About 150 participants will receive either CAL101 or a placebo by IV infusion once a month for 6 months. The main goal is to see if CAL101 helps preserve breathing capacity compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AORN - Ospedali dei Colli - Ospedale V. Monaldi
Naples, 80131, Italy
-
AP-HP Hopital Avicenne
Bobigny, 93000, France
-
AP-HP Hopital Europeen Georges Pompidou
Paris, 75015, France
-
Aarhus University Hospital
Aarhus, 8200, Denmark
-
Ajou University Hospital
Suwon, Gyeonggi-do, 16499, South Korea
-
Akershus University Hospital
Lørenskog, 1478, Norway
-
Asan Medical Center
Seoul, 05505, South Korea
-
Azienda Ospedale - Università Padova
Padova, PD, 35128, Italy
-
Azienda Ospedaliero Universitaria Senese
Siena, SI, 53100, Italy
-
Azienda Ospedaliero-Universitaria di Modena
Modena, 41124, Italy
-
Azienda sanitaria universitaria Giuliano Isontina (ASU GI) - Ospedale di Cattinara
Trieste, TS, 34149, Italy
-
Birmingham Heartlands Hospital
Birmingham, B9 5SS, United Kingdom
-
CHRU de Tours - Hôpital Bretonneau
Tours, 37000, France
-
CHU Rennes - Hopital Pontchaillou
Rennes, 35000, France
-
CHU de Toulouse - Hopital Larrey
Toulouse, 31059 Cedex 9, France
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Ege University Medical Faculty Hospital
Izmir, 35100, Turkey (Türkiye)
-
Erasmus MC
Rotterdam, South Holland, 3015 GD, Netherlands
-
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
Roma, RM, 00168, Italy
-
Haukeland University Hospital
Bergen, 5021, Norway
-
Hospital Clinico Universitario de Santiago
Santiago de Compostela, 15706, Spain
-
Hospital Universitario Marqués de Valdecilla
Santander, 39008, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain
-
Institutul de Pneumoftiziologie Marius Nasta
Bucharest, 050159, Romania
-
Istituto Clinico Humanitas - Pneumologia 1
Rozzano, 20089, Italy
-
Keck School of Medicine at USC
Los Angeles, California, 90033, United States
-
Leeds Teaching Hospitals NHS Trust
Leeds, LS9 7TF, United Kingdom
-
Manchester University NHS Foundation Trust
Manchester, M23 9QZ, United Kingdom
-
NHS Lothian, Edinburgh Royal Infirmary
Edinburgh, EH16 4SA, United Kingdom
-
National Jewish Health
Denver, Colorado, 80206, United States
-
Odense University Hospital
Odense, 5000, Denmark
-
Oslo University Hospital, Rikshospitalet
Oslo, 0372, Norway
-
Oxford University Hospitals NHS Foundation Trust
Oxford, OX3 7LE, United Kingdom
-
Pulmonix, LLC
Greensboro, North Carolina, 27403, United States
-
Queen Elizabeth Hospital Birmingham
Birmingham, B15 2GW, United Kingdom
-
Rigshospitalet
Copenhagen, 2100, Denmark
-
Royal Brompton Hospital
London, SW3 6HP, United Kingdom
-
Royal Victoria Infirmary
Newcastle upon Tyne, NE1 4LP, United Kingdom
-
Seoul National University Bundang Hospital
Gyeonggi-do, 13620, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Southeastern Research Center
Winston-Salem, North Carolina, 27103, United States
-
Spitalul Clinic de Boli Infectioase si Pneumoftiziologie ''Victor Babes'' Craiova
Craiova, Dolj, 200515, Romania
-
Spitalul Clinic de Boli Infectioase si Pneumoftiziologie dr. Victor Babes Timisoara
Timișoara, Timiș County, 300310, Romania
-
Spitalul Clinic de Pneumoftiziologie ''Leon Daniello''
Cluj-Napoca, Cluj, 400371, Romania
-
St. Antonius Ziekenhuis - Locatie Nieuwegein
Nieuwegein, Utrecht, 3435 CM, Netherlands
-
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
-
Uludag University Medical Faculty
Bursa, 16059, Turkey (Türkiye)
-
University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
-
University of Health Sciences Gulhane Faculty of Medicine
Ankara, 06010, Turkey (Türkiye)
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Utah Health
Salt Lake City, Utah, 84108, United States
-
Y & L Advance Health Care, Inc. d/b/a Elite Clinical Research
Miami, Florida, 33144, United States
Conditions
Explore the condition pages connected to this study.